Health ❯ Healthcare

Patient Outcomes

Survival Rates Quality of Life Mortality Rates Treatment Efficacy Progression-Free Survival Adverse Events Weight Loss Weight Management Early Detection Response Rates

Study Links PSMA PET/CT to 5-Year Outcomes, Informing Salvage Treatment After Prostatectomy

Authors frame the retrospective UCLA data as practice-informing evidence that warrants prospective validation.

Asundexian Cuts Recurrent Stroke 26% Without More Major Bleeding in Phase III

Treating Advanced Lung Cancer Before 3 p.m. Extends Survival in Phase III Trial

CagriSema Beats Semaglutide on HbA1c and Weight at 68 Weeks in Type 2 Diabetes Trial

Trials Show Fecal Transplants Enhance Cancer Immunotherapy, Including Longer PFS in Randomized Kidney Study

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Healthgrades Names 2026 America’s Best Hospitals, Highlights Uneven Access to Top Care

KLAS Validates ROI From Suki’s Ambient AI Across Three Health Systems

Moderna–Merck Personalized Melanoma Vaccine Sustains 5-Year Benefit, Cutting Recurrence Risk by 49%

Large ADHD Trial Finds No Benefit From FDA-Cleared Trigeminal Stimulation Device

Low CTDNEP1 Tied to Poorer Outcomes in Pancreatic Cancer, Study Finds

FDA Approves Zycubo, First U.S. Treatment for Menkes Disease

New Study Links Nurse Exodus to Higher Death Rates at German Hospitals Near Swiss Border

Late-Morning Heart Surgery Start Linked to Higher Cardiac Death Risk, UK Study Finds

Lilly Reports Zepbound Plus Taltz Beat Taltz Alone in Psoriatic Arthritis Trial

Pooled Data Tie Early AE Management to Greater Zolbetuximab Benefit in Gastric/GEJ Cancer

Yoga Add-On Halves Opioid Withdrawal Time in JAMA Psychiatry Trial

FDA Grants Orphan Drug Status to Cellenkos’ CK0804 for Myelofibrosis

Alumis TYK2 Pill Hits Phase 3 Goals in Psoriasis as Stock Jumps and $175 Million Offering Is Planned

Doctors Warn NHS Stroke Specialist Shortage Is Causing Preventable Death and Disability